Kala Bio (KALA) Amortizatization of Intangibles (2021)
Kala Bio (KALA) posted Amortizatization of Intangibles of $12000.0 for Q2 2021, up 20.0% sequentially from $10000.0 in Q1 2021.
Kala Bio (KALA) Amortizatization of Intangibles (2021) Analysis & Trends
Kala Bio has reported Amortizatization of Intangibles for 1 years, with the latest figure at $12000.0 in Q2 2021.
- Quarterly Amortizatization of Intangibles changed N/A year-over-year to $12000.0 in Q2 2021, while the trailing twelve-month figure through Dec 2021 was $22000.0 (changed N/A YoY) and the FY2021 annual result came in at $22000.0, up 540.0% from the prior year.
- Amortizatization of Intangibles improved to $12000.0 in Q2 2021 per KALA's latest filing, from $10000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $12000.0 in Q2 2021 and troughed at $10000.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Kala Bio | 9.89 Mn | 9.89 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 12,000.00 |
| Jun 30, 2021 | 12,000.00 |
| Mar 31, 2021 | 10,000.00 |
| Mar 31, 2021 | 10,000.00 |